Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must have already received a treatment called REACT (a gelatin-hydrogel formula) in a previous clinical trial (one of these: RMCL-002, REGEN-003, or REGEN-004) for chronic kidney disease, and completed all required visits in that trial.
Who may not be able to join:
- You did not receive the REACT treatment in one of the previous clinical trials mentioned above for chronic kidney disease.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Study Director, Prokidney
Phone: 336-999-7031
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary Endpoint: Long-term safety of REACT
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.